Rang	Name	Position
1	Dr. Alexandria Forbes Ph.D.	CEO, President & Director
2	Mr. Richard Brian Giroux B.A.	COO & CFO
3	Dr. Robert K. Zeldin M.D.	Chief Medical Officer
4	Mr. Robert J. Wollin J.D.	General Counsel & Secretary
5	Dr. Stuart Naylor Ph.D.	Chief Scientific Officer of Ophthalmology
6	Dr. Michel Michaelides F.A.C.S., M.D., MBBS	Head of Clinical Ophthalmology
7	Ms. Christine Elise Sheehy	Senior Vice President of Global Integration
8	Mr. Tim Randall	Senior Vice President of Risk & Internal Controls
9	Dr. David Rubinstein Ph.D.	Senior Vice President of Business Development
10	Dr. Tassos Georgiadis Ph.D.	Senior Vice President of Discovery & Preclinical Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Sanofi	12,70%	0,16 Mrd. USD
2	Perceptive Advisors LLC	11,23%	0,14 Mrd. USD
3	Rubric Capital Management LP	7,29%	0,09 Mrd. USD
4	Johnson & Johnson	6,91%	0,09 Mrd. USD
5	Adage Capital Partners Gp LLC	4,58%	0,06 Mrd. USD
6	Opaleye Management Inc	3,70%	0,05 Mrd. USD
7	BlackRock Inc	3,30%	0,04 Mrd. USD
8	Millennium Management LLC	3,09%	0,04 Mrd. USD
9	683 Capital Management LLC	2,55%	0,03 Mrd. USD
10	Morgan Stanley - Brokerage Accounts	1,66%	0,02 Mrd. USD
11	Knoll Capital Management LP	1,30%	0,02 Mrd. USD
12	Kennedy Capital Management Inc	1,15%	0,01 Mrd. USD
13	Long Focus Capital Management, LLC	1,12%	0,01 Mrd. USD
14	D. E. Shaw & Co LP	0,89%	0,01 Mrd. USD
15	State Street Corp	0,78%	0,01 Mrd. USD
16	Erste Asset Management GmbH	0,75%	0,01 Mrd. USD
17	Citadel Advisors Llc	0,68%	0,01 Mrd. USD
18	Geode Capital Management, LLC	0,61%	0,01 Mrd. USD
19	Partner Fund Management LP	0,47%	0,01 Mrd. USD
20	The Goldman Sachs Group Inc	0,46%	0,01 Mrd. USD